MDGL
#809
Madrigal Pharmaceuticals, Inc. - Common Stock
533.7 6 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.83%
Variación mensual
+9.77%
Variación en los últimos 6 meses
+24.06%
Cambio anual
+26.00%
Cierres anteriores
543.6 9
Open
533.7 6
Mínimo
533.7 6
Máximo
533.7 6
Volumen
81
Financials
- Market Capitalization 12.33 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-35.68
Relación precio/flujo de caja
10.67
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 759 |  EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | -2.35% | +39.47% | 13.49 B USD | ||
| 799 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +7.11% | +10.74% | 12.52 B USD | ||
| 810 |  CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | -3.57% | +55.21% | 12.31 B USD | ||
| 823 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | -2.32% | +117.16% | 11.99 B USD |